Cargando…

Infección por SARS-CoV-2 y ataque cerebrovascular isquémico

The new coronavirus SARS-CoV-2 is causing a huge impact on health, economy, and social dynamics. The world is facing an emerging viral disease for which no specific treatment is available, and many aspects of the clinical behavior of the disease are still unknown, which makes the diagnosis and manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Medina, Daniel S., Muñoz-Rosero, Angela María, Bernal-Bastidas, Bertha Ligia, Gaspar-Toro, Jorge Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587077/
https://www.ncbi.nlm.nih.gov/pubmed/33218946
http://dx.doi.org/10.1016/j.semerg.2020.09.007
_version_ 1783600119812194304
author Marín-Medina, Daniel S.
Muñoz-Rosero, Angela María
Bernal-Bastidas, Bertha Ligia
Gaspar-Toro, Jorge Mario
author_facet Marín-Medina, Daniel S.
Muñoz-Rosero, Angela María
Bernal-Bastidas, Bertha Ligia
Gaspar-Toro, Jorge Mario
author_sort Marín-Medina, Daniel S.
collection PubMed
description The new coronavirus SARS-CoV-2 is causing a huge impact on health, economy, and social dynamics. The world is facing an emerging viral disease for which no specific treatment is available, and many aspects of the clinical behavior of the disease are still unknown, which makes the diagnosis and management a big challenge. Various neurological manifestations have been described and associated with SARS-CoV-2 infection. Stroke occurs in up to 6% of all patients with COVID-19, a figure that becomes significant given the large number of patients diagnosed to date. The clinical characteristics, presentation, evolution, and prognosis of these patients seem to have peculiarities that have not been seen in previous forms of stroke. Every time younger patients are observed, without a medical history, without infectious symptoms, with serious neurological results that pose a challenging and difficult approach. This review synthesizes the information available on the clinical characteristics and the proposals for its management.
format Online
Article
Text
id pubmed-7587077
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-75870772020-10-27 Infección por SARS-CoV-2 y ataque cerebrovascular isquémico Marín-Medina, Daniel S. Muñoz-Rosero, Angela María Bernal-Bastidas, Bertha Ligia Gaspar-Toro, Jorge Mario Semergen Revisión The new coronavirus SARS-CoV-2 is causing a huge impact on health, economy, and social dynamics. The world is facing an emerging viral disease for which no specific treatment is available, and many aspects of the clinical behavior of the disease are still unknown, which makes the diagnosis and management a big challenge. Various neurological manifestations have been described and associated with SARS-CoV-2 infection. Stroke occurs in up to 6% of all patients with COVID-19, a figure that becomes significant given the large number of patients diagnosed to date. The clinical characteristics, presentation, evolution, and prognosis of these patients seem to have peculiarities that have not been seen in previous forms of stroke. Every time younger patients are observed, without a medical history, without infectious symptoms, with serious neurological results that pose a challenging and difficult approach. This review synthesizes the information available on the clinical characteristics and the proposals for its management. Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. 2021-10 2020-10-26 /pmc/articles/PMC7587077/ /pubmed/33218946 http://dx.doi.org/10.1016/j.semerg.2020.09.007 Text en © 2020 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revisión
Marín-Medina, Daniel S.
Muñoz-Rosero, Angela María
Bernal-Bastidas, Bertha Ligia
Gaspar-Toro, Jorge Mario
Infección por SARS-CoV-2 y ataque cerebrovascular isquémico
title Infección por SARS-CoV-2 y ataque cerebrovascular isquémico
title_full Infección por SARS-CoV-2 y ataque cerebrovascular isquémico
title_fullStr Infección por SARS-CoV-2 y ataque cerebrovascular isquémico
title_full_unstemmed Infección por SARS-CoV-2 y ataque cerebrovascular isquémico
title_short Infección por SARS-CoV-2 y ataque cerebrovascular isquémico
title_sort infección por sars-cov-2 y ataque cerebrovascular isquémico
topic Revisión
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587077/
https://www.ncbi.nlm.nih.gov/pubmed/33218946
http://dx.doi.org/10.1016/j.semerg.2020.09.007
work_keys_str_mv AT marinmedinadaniels infeccionporsarscov2yataquecerebrovascularisquemico
AT munozroseroangelamaria infeccionporsarscov2yataquecerebrovascularisquemico
AT bernalbastidasberthaligia infeccionporsarscov2yataquecerebrovascularisquemico
AT gaspartorojorgemario infeccionporsarscov2yataquecerebrovascularisquemico